Back to Journals » Neuropsychiatric Disease and Treatment » Volume 16

The Effectiveness of Occupational Therapy-Based Sleep Interventions on Quality of Life and Fatigue in Patients with Multiple Sclerosis: A Pilot Randomized Clinical Trial Study

Authors Akbarfahimi M, Nabavi SM, Kor B, Rezaie L, Paschall E

Received 25 February 2020

Accepted for publication 13 May 2020

Published 29 May 2020 Volume 2020:16 Pages 1369—1379

DOI https://doi.org/10.2147/NDT.S249277

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Roger Pinder


Malahat Akbarfahimi,1 Seyed Massood Nabavi,2 Benyamin Kor,3 Leeba Rezaie,4 Ethan Paschall5

1Department of Occupational Therapy, School of Rehabilitation Sciences, Neuroscience Research Center, Iran University of Medical Sciences, Tehran, Iran; 2Regenerative Biomedicine Department, Cell Research Center, Royan Institute for Stem Cell Biology and Technology, ACCR, Tehran, Iran; 3Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran; 4Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran; 5Clinical Psychology, Eastern Michigan University, Ypsilanti, Michigan, USA

Correspondence: Benyamin Kor
Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Mother Square, Tehran, Iran
Email Benyamin.kor@gmail.com
Leeba Rezaie
Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Dovlat Abad Blvd., Kermanshah, Iran
Tel +98 188364414
Fax +98 8338265255
Email rezaie.phd.ot@gmail.com

Purpose: Sleep difficulties are common in patients with multiple sclerosis (MS), which may increase feelings of fatigue, negatively interfere with daily activities, and consequently reduce their quality of life. Studies examining the effects of sleep-targeted interventions in MS are currently limited in the literature. Therefore, we aim to assess the effects of occupational therapy interventions on sleep quality, fatigue, and quality of life in patients with MS.
Patients and Methods: In a single-blind, randomized, controlled trial, which occurred between April 2018 and March 2019 in Tehran, Iran, 20 eligible patients with MS were assessed using the Pittsburgh Sleep Quality Index (PSQI), Fatigue Impact Scale (FIS), Fatigue Severity Scale (FSS), and Short-Form Health Survey (SF-36). Patients were allocated randomly into the two following groups: patients receiving care-as-usual for MS (CAU) and patients receiving care-as-usual plus intervention (CAU + intervention). Both intervention groups underwent 2– 3 sessions per week lasting 30– 45 minutes for 8 weeks and received follow-up assessments. Data were analyzed using independent sample t-tests and Mann–Whitney U tests using SPSS (16 ver.) statistical software.
Results: In the intervention group, sleep quality improved significantly across all items (p< 0.001, effect size = 0.60) except for sleep efficiency and the use of sleep medications. FSS and FIS in the sleep intervention group were significantly reduced (p< 0.001, effect size = 0.76 and p< 0.001, effect size = 0.82, respectively). The quality of life in the intervention group improved significantly (p< 0.004, effect size = 0.51– 0.76) with the exception of the social functioning subgroup.
Conclusion: Although this is the result of a pilot study and more patients should be added, this intervention program demonstrates improvement in sleep quality and quality of life while decreasing fatigue in patients with MS. Adjunction of this program, if results are similar with more patients, to routine occupational therapy (OT) interventions can help improve the rehabilitation program of MS patients.

Keywords: sleep quality, quality of life, fatigue, multiple sclerosis, sleep interventions, occupational therapy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]